Ansal Buildwell Intrinsic Value
Ansal Buildwell (ANSALBU) median intrinsic value is ₹185.71 from 4 valuation models (range ₹69–₹186), vs current price ₹74.50 — +149.3% upside (Trading Below Calculated Value), margin of safety 59.9%. Read Ansal Buildwell dividend payments for the complete payout history and dividend yield track record.
ANSALBU Valuation Methods Summary — DCF, Graham Number & P/E
Ansal Buildwell intrinsic value across 4 models vs current price ₹74.50 — upside/downside and value range per method. Analyse ANSALBU promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹185.71 | ₹167.14 - ₹204.28 | +149.3% | Book Value/Share: ₹185.71, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹68.57 | ₹61.71 - ₹75.43 | -8.0% | Revenue/Share: ₹85.71, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹68.57 | ₹61.71 - ₹75.43 | -8.0% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹186.25 | ₹149.00 - ₹223.50 | +150.0% | CF Growth: 5.0%, Discount: 15% |
ANSALBU Intrinsic Value vs Market Price — All Valuation Models
Ansal Buildwell fair value range ₹69–₹186 vs current market price ₹74.50 across 4 valuation models. For current market price and key ratios, visit Ansal Buildwell stock price NSE.
ANSALBU Intrinsic Value Analysis — Undervalued or Overvalued?
Ansal Buildwell median intrinsic value ₹185.71, current price ₹74.50 — Trading Below Calculated Value by 149.3%, margin of safety 59.9%.
What is the intrinsic value of ANSALBU?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Ansal Buildwell (ANSALBU) is ₹185.71 (median value). With the current market price of ₹74.50, this represents a +149.3% variance from our estimated fair value.
The valuation range spans from ₹68.57 to ₹186.25, indicating ₹68.57 - ₹186.25.
Is ANSALBU undervalued or overvalued?
Based on our multi-method analysis, Ansal Buildwell (ANSALBU) appears to be trading below calculated value by approximately 149.3%.
ANSALBU Financial Health — Key Ratios vs Industry Benchmarks
Ansal Buildwell financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.76 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -6.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.11x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ANSALBU Cash Flow Quality — Operating & Free Cash Flow
Ansal Buildwell operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-4 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹20 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹61 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹24 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |